Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Covidien plans to sell some vascular therapies ahead of Medtronic merger; Covidien, Medtronic shares jump on affirmation of $43B merger; Wright Medical to acquire Tornier for $3.3B in inversion deal; Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic; Globus Medical snaps up allograft maker Transplant Technologies
Covidien unveils the next generation of its superDimension device for lung imaging procedures.
Covidien (NYSE:COV) today unveiled the next generation of its superDimension navigation software for lung procedures.
Covidien says it plans to divest its some of its vascular therapies business to mollify U.S. anti-trust regulators about its proposed $43 billion merger with Medtronic.
A look at the top 10 politicial action committee donations shows that medtech is betting heavily on a GOP win in the midterm elections.
The medical device industry is betting on a Republican sweep of the U.S. Congress during the 2014 mid term elections, according to a MassDevice.com analysis of donations made by the industry's 10 largest political action committees.
Medtronic issues an update on the debt financing behind its pending $43 billion acquisition of Covidien.
In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.
Despite stroke being the 2nd leading cause of death worldwide, many people still don't recognize risk factors and warning signs, according to a new poll sponsored by Covidien and the World Stroke Organization.